Role of prebiotics in regulation of microbiota and prevention of obesity

Food Research International

Volumn 113, Issue , 2018, Pages 183-188

  Choque Delgado, Grethel Teresa ^a   Tamashiro, Wirla Maria da Silva Cunha ^b  

^a UNIVERSIDAD NACIONAL DE SAN AGUSTÍN DE AREQUIPA   (Peru)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

FOS; Intestinal microbiota; Metabolism; Modulation; Obesity; Prebiotics

Indexed keywords

METABOLISM; MODULATION;

EXPERIMENTAL MODELS; GOVERNMENTAL INVESTMENTS; IDENTIFICATION OF RISKS; METABOLIC SYNDROMES; MICROBIOTAS; NON-COMMUNICABLE DISEASE; OBESITY; PREBIOTICS;

NUTRITION;

PREBIOTIC AGENT;

ANIMAL; BIFIDOBACTERIUM; DIET; DRUG EFFECT; FERMENTATION; FUNCTIONAL FOOD; GLUCOSE BLOOD LEVEL; HEALTH PROMOTION; HUMAN; INTESTINE FLORA; LACTOBACILLUS; LIPID METABOLISM; METABOLISM; OBESITY; PHYSIOLOGY; SATIETY;

ANIMALS; BIFIDOBACTERIUM; BLOOD GLUCOSE; DIET; FERMENTATION; FUNCTIONAL FOOD; GASTROINTESTINAL MICROBIOME; HEALTH PROMOTION; HUMANS; LACTOBACILLUS; LIPID METABOLISM; OBESITY; PREBIOTICS; SATIATION;

EID: 85049611590     PISSN: 09639969     EISSN: 18737145     Source Type: Journal    
DOI: 10.1016/j.foodres.2018.07.013     Document Type: Review

References (57)

1. Bomhof, M.R., Saha, D.C., Reid, D.T., Paul, H.A., Reimer, R.A., Combined effects of oligofructose and Bifidobacterium animalis on gut microbiota and glycemia in obese rats. Obesity (Silver Spring) 22:3 (2014), 763–771.
2. Campbell, P.J., Carlson, M.G., Hill, J.O., Nurjhan, N., Regulation of free fatty acid metabolism by insulin in humans: Role of lipolysis and reesterification. American Journal of Physiology 263 (1992), E1063–E1069.
3. Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Delzenne, N.M., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58 (2009), 1091–1103.
4. Carabin, I.G., Flamm, W.G., Evaluation of safety of inulin and oligofructose as dietary fiber. Regulatory Toxicology and Pharmacology 30 (1999), 268–282.
5. De Carvalho, M.A.M., Figueiredo-Ribeiro, R.C.L., Frutanos: ocorrência, estrutura e utilização, com ênfase em plantas do cerrado brasileiro. Lajolo, F.M., Saura-Calixto, F., Penna, E.W., Menezes, E.W., (eds.) Fibra Dietética en Iberoamérica: Tecnología y Salud – Obtención, Caracterización, Efecto Fisiológico y Aplicación en Alimentos, 2001, Livraria Varela, São Paulo, 77–89.
6. Choque-Delgado, G.T., Thomé R., Gabriel, D.L., Tamashiro, W.M.S.C., Pastore, G., Yacon (Smallanthus sonchifolius)-derived fructooligosaccharides improves the immune parameters in the mouse. Nutrition Research 32 (2012), 884–892.
7. Connolly, M.L., Lovegrove, J.A., Tuohy, K.M., In vitro fermentation characteristics of whole grain wheat flakes and the effect of toasting on prebiotic potential. Journal of Medicinal Food 15:1 (2012), 33–43.
8. Dahiya, D.K., Renuka, P.M., Shandilya, U.K., Dhewa, T., Kumar, N., Kumar, S., Shukla, P., Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics: A review. Frontiers in Microbiology, 8, 2017, 563 Apr 4.
9. Dewulf, E.M., Cani, P.D., Claus, S.P., Fuentes, S., Puylaert, P.G., Neyrinck, A.M., Delzenne, N.M., Insight into the prebiotic concept: Lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62:8 (2013), 1112–1121.
10. Everard, A., Cani, P.D., Diabetes, obesity and gut microbiota. Best Practice & Research Clinical Gastroenterology 27 (2013), 73–83.
11. Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G.G., Neyrinck, A.M., Cani, P.D., Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60:11 (2011), 2775–2786.
12. Fenyvesi, É., Vikmon, M., Szente, L., Cyclodextrins in food technology and human nutrition: Benefits and limitations. Critical Reviews in Food Science and Nutrition 56:12 (2016), 1981–2004 Sep 9.
13. Frayn, K.N., Karpe, F., Fielding, B.A., MacDonald, I.A., Coppack, S.W., Integrative physiology of human adipose tissue. International Journal of Obesity 27 (2003), 875–888.
14. Geurts, L., Neyrinck, A.M., Delzenne, N.M., Knauf, C., Cani, P.D., Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: Novel insights into molecular targets and interventions using prebiotics. Beneficial Microbes 5:1 (2014), 3–17.
15. Gibson, G.R., Prebiotics as gut microflora management tools. Journal of Clinical Gastroenterology 42 (2008), 75–79.
16. Gibson, G.R., Hutkins, R., Sanders, M.E., Prescott, S.L., Reimer, R.A., Salminen, S.J., Reid, G., Expert consensus document: The international scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews. Gastroenterology & Hepatology 14:8 (2017), 491–502 Aug.
17. Giménez Palop, O., Caixà A., Péptido YY: una nueva estrategia para el tratamiento de la obesidad. Endocrinología y Nutrición 56:1 (2009), 1–3.
18. Grajek, W., Olejnik, A., Sip, A., Probiotics, prebiotics and antioxidants as functional foods. Acta Biochimica Polonica 52:3 (2005), 665–671.
19. Hersoug, L.G., Møller, P., Loft, S., Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: Implications for inflammation and obesity. Obesity Reviews 17:4 (2016), 297–312.
20. Hoseinifar, S.H., Khalili, M., Rostami, H.K., Esteban, M.Á., Dietary galactooligosaccharide affects intestinal microbiota, stress resistance, and performance of Caspian roach (Rutilus rutilus) fry. Fish & Shellfish Immunology 35:5 (2013), 1416–1420.
21. Hospedales, C.J., Jané-Llopis, E.A., Multistakeholder platform to promote health and prevent noncommunicable diseases in the region of the Americas: The Pan American Health Organization partners forum for action. Journal of Health Communication 16:2 (2011), 191–200.
22. John, G.K., Wang, L., Nanavati, J., Twose, C., Singh, R., Mullin, G., Dietary alteration of the gut microbiome and its impact on weight and fat mass: A systematic review and meta-analysis. Genes (Basel), 9(3), 2018 Mar 16. pii: E167.
23. Lecerf, J.M., Depeint, F., Clerc, E., Dugenet, Y., Niamba, C.N., Rhazi, L., Pouillart, P.R., Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. British Journal of Nutrition 108 (2012), 1847–1858.
24. de Luis, D.A., de la Fuente, B., Izaola, O., Conde, R., Gutiérrez, S., Morillo, M., Teba Torres, C., Double blind randomized clinical trial controlled by placebo with an alpha linoleic acid and prebiotic enriched cookie on risk cardiovascular factor in obese patients. Nutrición Hospitalaria 26:4 (2011), 827–833.
25. McGavigan, A.K., Murphy, K.G., Gut hormones: The future of obesity treatment?. British Journal of Clinical Pharmacology 74 (2012), 911–919.
26. Mischke, M., Arora, T., Tims, S., Engels, E., Sommer, N., van Limpt, K., Knol, J., Specific synbiotics in early life protect against diet-induced obesity in adult mice. Diabetes, Obesity and Metabolism 20:6 (2018), 1408–1418 Jun.
27. Nicolucci, A.C., Hume, M.P., Martínez, I., Mayengbam, S., Walter, J., Reimer, R.A., Prebiotics reduce body fat and Alter intestinal microbiota in children who are overweight or with obesity. Gastroenterology 153:3 (2017), 711–722.
28. Nihei, N., Okamoto, H., Furune, T., Ikuta, N., Sasaki, K., Rimbach, G., Terao, K., Dietary α-cyclodextrin modifies gut microbiota and reduces fat accumulation in high-fat-diet-fed obese mice. BioFactors, May 7, 2018, 10.1002/biof.1429 (Epub ahead of print).
29. Nilsson, A., Johansson, E., Ekström, L., Björck, I., Effects of a Brown beans evening meal on metabolic risk markers and appetite regulating hormones at a subsequent standardized breakfast: A randomized cross-over study. PLoS One, 8(4), 2013, e59985.
30. Nilsson, A., Östman, E., Preston, T., Björck, I., Effects of GI vs content of cereal fibre of the evening meal on glucose tolerance at a subsequent standardized breakfast. European Journal of Clinical Nutrition 62 (2008), 712–720.
31. Pan American Health Organization, Regional Strategy and Plan of Action on an Integrated Approach to the Prevention and Control of Chronic Diseases. 2007, Author, Washington, DC.
32. Parnell, J.A., Klancic, T., Reimer, R.A., Oligofructose decreases serum lipopolysaccharide and plasminogen activator inhibitor-1 in adults with overweight/obesity. Obesity (Silver Spring) 25:3 (2017), 510–513 Mar.
33. Parnell, J.A., Reimer, R.A., Effect of prebiotic fibre supplementation on hepatic gene expression and serum lipids: A dose-response study in JCR:LA-cp rats. British Journal of Nutrition 103:11 (2010), 1577–1584.
34. Passos, M.L., Park, Y.K., Frutooligossacarídeos: implicações na saúde humana e utilização em alimentos. Ciência Rural 33:2 (2003), 385–390.
35. Peeva, E., Brun, D.L., Vem, M., Despre's, J.P., Normand, T., Gagné C., Julien, P., Adipose cell size and distribution in familial lipoprotein lipase deficiency. International Journal of Obesity and Related Metabolic Disorders 16 (1992), 737–744.
36. Posovszky, C., Wabitsch, M., Regulation of appetite, satiation, and body weight by enteroendocrine cells. Part 2: Therapeutic potential of enteroendocrine cells in the treatment of obesity. Hormone Research in Pædiatrics 83 (2015), 11–18.
37. Pyra, K.A., Saha, D.C., Reimer, R.A., Prebiotic fiber increases hepatic acetyl CoA carboxylase phosphorylation and suppresses glucose-dependent insulinotropic polypeptide secretion more effectively when used with metformin in obese rats. Journal of Nutrition 142:2 (2012), 213–220.
38. Reimer, R.A., Russell, J.C., Glucose tolerance, lipids, and GLP-1 secretion in JCR:LA-cp rats fed a high protein fiber diet. Obesity (Silver Spring) 16:1 (2008), 40–46.
39. Respondek, F., Gerard, P., Bossis, M., Boschat, L., Bruneau, A., Rabot, S., Martin, J.C., Short-chain fructo-oligosaccharides modulate intestinal microbiota and metabolic parameters of humanized gnotobiotic diet induced obesity mice. PLoS One, 8(8), 2013, e71026 12.
40. Rizza, R.A., Mandarino, L.J., Gerich, J.E., Dose–response characteristics for effects of insulin on production and utilization of glucose in man. American Journal of Physiology 240 (1981), E630–E639.
41. Roberfroid, M., Gibson, G.R., Delzenne, N., The biochemistry of oligofructose, a nondigestible fiber: An approach to calculate its caloric value. Nutrition Reviews 51:5 (1993), 137–146.
42. Roberfroid, M., Gibson, G.R., Hoyles, L., McCartney, A.L., Rastall, R., Rowland, I., Meheust, A., Prebiotic effects: Metabolic and health benefits. British Journal of Nutrition 104:2 (2010), S1–63.
43. Roth, C.L., Reinehr, T., Roles of gastrointestinal and adipose tissue peptide in childhood obesity and changes after weight loss due to lifestyle intervention. Archives of Pediatrics & Adolescent Medicine 164 (2010), 131–138.
44. Sako, T., Matsumoto, K., Tanaka, R., Recent progress on research and application of non-digestible galacto-oligosaccharides. International Dairy Journal 9 (1999), 69–80.
45. Salazar, N., Dewulf, E.M., Neyrinck, A.M., Bindels, L.B., Cani, P.D., Mahillon, J., Delzenne, N.M., Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clinical Nutrition 34 (2015), 501–507.
46. Santos, R., Simiqueli, A.P., Pastore, G.M., Produção de galactooligossacarídeo por Scopulariopis sp. Ciência e Tecnologia de Alimentos. 29:3 (2009), 682–689.
47. Satoh, H., Audrey, Nguyen, M.T., Kudoh, A., Watanabe, T., Yacon diet (Smallanthus sonchifolius, Asteraceae) improves hepatic insulin resistance via reducing Trb3 expression in Zucker fa/fa rats. Nutrition & Diabetes 27 (2013), 3–70.
48. Savignac, H.M., Corona, G., Mills, H., Chen, L., Spencer, J.P., Tzortzis, G., Burnet, P.W., Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-d-aspartate receptor subunits and d-serine. Neurochemistry International 63:8 (2013), 756–764.
49. Tolhurst, G., Heffron, H., Lam, Y.S., Parker, H.E., Habib, A.M., Diakogiannaki, E., Gribble, F.M., Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein–coupled receptor FFAR2. Diabetes 61:2 (2012), 364–371.
50. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:7122 (2006), 1027–1031 21.
51. Verbrugghe, A., Hesta, M., Gommeren, K., Daminet, S., Wuyts, B., Buyse, J., Janssens, G.P., Oligofructose and inulin modulate glucose and amino acid metabolism through propionate production in normal-weight and obese cats. British Journal of Nutrition 102:5 (2009), s694–s702.
52. Wagner, E.M., Jen, K.-L.C., Artiss, J.D., Remaley, A.T., Dietary alpha-cyclodextrin lowers low-density lipoprotein cholesterol and alters plasma fatty acid profile in low-density lipoprotein receptor knockout mice on a high-fat diet. Metabolism, Clinical and Experimental 57 (2008), 1046–1051.
53. Wang, H., Eckel, R.H., Lipoprotein lipase: From gene to obesity. American Journal of Physiology. Endocrinology and Metabolism 297:2 (2009), E271–E288.
54. World Health Organization, Global status report on NCDs. Retrieved July 4, 2013 http://www.who.int/nmh/publications/ncd_report_full_en.pdf, 2010.
55. World Health Organization, Obesity and overweight. Accessed 13 March, 2018 http://www.who.int/mediacentre/factsheets/fs311/en/, 2018.
56. Wormser, D., Kaptoge, S., Di Angelantonio, E., Wood, A.M., Pennells, L., Thompson, A., Danesh, J., Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: Collaborative analysis of 58 prospective studies. Lancet 377 (2011), 1085–1095.
57. Xiao, S., Fei, N., Pang, X., Shen, J., Wang, L., Zhang, B., Zhao, L., A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiology Ecology 87:2 (2014), 357–367.